Neonatal Abstinence Syndrome

Similar documents
Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Neonatal Abstinence Syndrome

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Neonatal Abstinence: The epidemic Its Impact on All of Us

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Drug Withdrawal

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Nursing Care of the NAS Infant. Lori Markham MSN, MBA, ARNP, NNP-BC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Brief History of Methadone Maintenance Treatment

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Understanding Prenatal Drug Exposure

Outcomes of Infants with Neonatal Abstinence Syndrome

Neonatal abstinence syndrome

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Objectives. Nothing to Disclose No Conflicts of Interest

Neonatal Abstinence Syndrome:

ADDICTION IN PREGNANCY

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Supplementary Appendix

Running head: NEONATAL ABSTINENCE SYNDROME 1

Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance

IN-PATIENT PEDIATRIC REHABILITATION

Neonatal Abstinence Syndrome (NAS)

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Wales Neonatal Network Guideline

Neonatal Abstinence Syndrome Epidemiology, diagnosis, management and prevention

Neonatal Abstinence Syndrome

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Objectives. Common Drugs leading to NAS. Differential Diagnosis. Clinical Features of NAS. Assessing Neonatal Abstinence in the Newborn Nursery

Prescription Opioids

Neonatal Abstinence Syndrome:

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

Medication for the Treatment of Addiction (MAT)

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Methadone and Pregnancy

SERVING SUBSTANCE EXPOSED NEWBORNS IN HARFORD COUNTY

Neonatal Abstinence Syndrome In Kentucky. Annual Report. From the Public Health Neonatal Abstinence Syndrome Reporting Registry

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

The Opioid-Exposed Woman

Neonatal Abstinence: It s No Child s Play!

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

NAS / NOWS: Description. Disclosures: I will discuss off-label uses of medications I have no financial disclosures. Objectives

Treating Women for Substance Use Disorders and Their Children: Evidence-based Care

Effects of Prenatal Illicit Drug. Use on Infant and Child

Talking with your doctor

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Opioid Use and Other Trends

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

NEONATAL ABSTINENCE SYNDROME. Michael Donnelly, D.O., PGY-2 Lake Cumberland Regional Hospital Somerset, KY

Neonatal Abstinence Syndrome (NAS)

Tapering Opioids Best Practices*

GOALS AND OBJECTIVES

Opiate Use Disorder and Opiate Overdose

Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome.

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot

Neonatal Abstinence Syndrome: A Retrospective Review of Clonidine as an Adjunct to Opioid Treatment

Introducing the Snuggle ME Recommendations: Care of Pregnant Women with Perinatal Substance Use with a Focus on Pain Management

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3

PERINATAL TOBACCO USE

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

Opiate Use in Reproductive Age Females

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

8/27/2018. Katie Brooks, DO, FAAP CHI Health St. Elizabeth. I have nothing to disclose

MAT in the Corrections Setting

Buprenorphine as a Treatment Option for Opioid Use Disorder

March 20 th, Public Health Approaches to Addressing Neonatal Abstinence Syndrome

A New approach to NAS: home in 6 days

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

A System of Care Surrounding the Drug Exposed Neonate. Disclosures. Objectives 11/17/2015. I have no financial disclosures

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

The Impact of Neonatal Abstinence Syndrome: The View from a Rural Kentucky Hospital

Neonatal Narcotic Abstinence Syndrome: A National Epidemic

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Ohio Perinatal Quality Collaborative

using analytics to identify and strategically manage patient opioid abuse

Transcription:

Neonatal Abstinence Syndrome TAMARA HARVANKO RN, BAN HIGH RISK OB CARE COORDINATOR CASE MANAGEMENT HENNEPIN COUNTY MEDICAL CENTER TAMARA.HARVANKO@HCMED.ORG 612-873-6552

https://www.youtube.com/watch?v=tk2hoyupkvi &feature=youtu.be

CDC data 30%, 68%, and 91% of NAS infants required pharmacologic treatment in separate studies Mean length of hospital stay: 23 days Mean hospital charge: $93,400 per infant Total cost: $1.5 billion Medicaid is most common payer ($1.2 billion) Strauss ME, Andresko M, Stryker JC, et al. Am J Obstet Gynecol. 1974 Dec 1;120(7):895-900. Ebner N, Rohrmeister K, Winklbaur B, et al. Drug Alcohol Depend. 2007 Mar 16;87(2-3):131-8. Patrick SW, Davis MM, Lehmann CU, et al. J Perinatol. 2015 Aug;35(8):650-5. Kuschel C. Semin Fetal Neonatal Med. 2007 Apr;12(2):127-33. Greig E, Ash A, Douiri A. Arch Gynecol Obstet. 2012 Oct;286(4):843-51.

Estimated cost for 25 newborns (HCMC) $1,492,000

Drug Withdrawal Withdrawal are a set of physical and emotional symptoms that occur with a decrease in the amount or abrupt discontinuation of drugs, nicotine, alcohol or prescription medications Withdrawal can happen after prolonged exposure to substances such as; Caffeine Nicotine Prescription medications (anti depressants) SSRI Opioid s ; Methadone, fentanyl, oxycodone, heroin etc Benzodiazepines; Valium, Ativan, Xanax, etc Alcohol

2016 HCMC had 44 opiate exposed newborns were born here in 2016 (total births 2021) Illicit or prescribed 25 of those newborns needed Medical management with morphine, some with additional phenobarbital Of the 25 medically managed NAS kiddos there were 746 NBICU days with an average length of stay of 31 days. 746 NBCIU days average $2000.00/day

Neonatal Abstinence Syndrome

Newborn Withdrawal Neonatal abstinence syndrome occurs after baby is born and the umbilical cord is cut. The steady supply of medications or substances is abruptly stopped Symptoms present 48-72 hours after birth

Babies are NOT born addicted!!!

What are symptoms of withdrawal? Baby unable to stop crying Jitteriness and. tremors. Feeding problems and poor weight gain. Fast breathing. Difficulty sleeping. Tense arms and legs. Vomiting, diarrhea and skin breakdown from diaper changes or frequent stools

Gabapentin Street name; Morontin or gabbies Prescribed as anti-epileptic, neuropathic pain, nerve pain. Off label use bipolar, insomnia, and hyperemesis in pregnancy. gabapentin may provide a euphoric high that may be similar to that produced by marijuana, bringing an increase in sociability and inducing feelings of calm to recreational users.

Gabapentin withdrawal case study Maternal 31 year old, parapalegic Gabapentin 600 mg TID prescribed since MVA at age 20 and sustained a C6-7 incomplete transection injury to spinal cord. Medications prescribed for neuropathic pain and prescriptions continued during pregnancy. Baclofen 30 mg QID, oxybutynin 10 MG/day Newborn Symptoms associated with drug withdrawal by 24 hours of life including; sneezing irritability jitteriness and loose stools. The overall clinical picture raised initial concerns for possible withdrawal syndrome from prolonged in utero gabapentin exposure. Treatment started at 36 hours with Lorazepam, at 0.5 mg/kg every 6 hours, after withdrawal scores ranged from 15 to 19 Scores remained elevated, and needed an escalated dose of Ativan on day of life 5 (.15 mg/kg every 6 hours) Day 6 team started gabapentin at 2.5 mg/kg every 12, increased on day 7 to 5 mg/kg. Which showed improvement in Finnegan scores once Gabapentin treatment started. Day 8 started weaning lorazepam. Lorazepam discontinued on day 10. Able to nipple all feedings by day of life 24 Pediatric Neurology 53 (2015) 445-447 Neonatal Gabapentin withdrawal Syndrome Melisa Carrasco MD, PhD, Sanajai C Rao DO, Cynthia F Bearer MD, PhD, Sripriya Sundararajan MBBS, MD

Scoring tools

Non pharmacologic Comfort measures Loud noises increase their distress. Turn down TVs and music Limit loud voices Dim overhead lights Routine is very important Babies will respond more positively when caregivers use soft voices and speak and move slowly.

Comfort techniques Mom s not using street drugs and are HIV negative we want you to breastfeed. If taking methadone, there will be a small amount of methadone in your breastmilk, this will not hurt your baby and may help your baby withdrawal easier. Wrapping baby snug in a blanket. Feeding baby small amounts more often.

Breastfeeding is encouraged and breast practices!

Smoking and NAS

Comparing Medication Assisted Treatment The Buprenorphine exposed babies; Required 89% less morphine to treat NAS Spent 43% less times in the hospital Spent 58% less time in the hospital being medicated for NAS Both medications in the context of comprehensive care produces similar maternal treatment and delivery outcomes Jones et al., N Engl J Med. 2010

Methadone Buprenorphine Better retention in care Less slips/or relapse 89% less morphine to treat neonatal abstinence syndrome, a 43% shorter hospital stay 58% shorter duration of medical treatment for neonatal abstinence syndrome More illicit use of opiates

746 NBCIU days average $2000.00/day = $1492,000

So there are trade-offs depending on which side of the umbilical cord you work.

Only qualified doctors with the necessary DEA (Drug Enforcement Agency) identification number are able to start in-office treatment and provide prescriptions for ongoing medication. CSAT (Center for Substance Abuse Treatment) will maintain a database to help patients locate qualified doctors. Complete at least 8 hours of approved training on the treatment and management of opioid-dependent patients First year waivered physicians can prescribe to 30 patients concurrently (including both detoxification and maintenance) during their first year After the first year, they may treat up to 100 patients concurrently in each subsequent year. Minnesota currently has approximately 120 Buprenorphine waivered prescribers.

New Legislation August 5 th Patient cap raised to 275 for addiction Medicine physicians July CARA act signed into law Opens prescribing to ANP s and PA s

Management of NAS Baby will need to stay need to stay in the hospital a minimum of 3-5 days after birth. Baby watched for signs of withdrawal. Inpatient nurses will use a scoring system such as Finnegan s. If baby does need medicine for withdrawal, we will then treat your baby in the Neonatal Intensive Care Unit (NICU). Additional risk factors are likely to make for a longer hospitalization such as you smoking cigarettes, or taking benzodiazepine s, such as Ativan, Clonazepam, Xanax, and Valium, Gabapentin during your pregnancy.

Medical management of Neonatal Opiate Withdrawal If 3 scores are >8 or 2 >12: Begin oral morphine 0.07mg/kg/dose q 3 hours Maximum dose of morphine 0.2mg/kg/dose q 3 hours Wean with scores less than 6 by 0.02mg/kg/dose of Morphine Rescue dosing is sometimes used. This is an extra dose of Morphine If weaning fails or you reach maximum dose of Morphine, consider adding clonidine or phenobarbital. When making decisions on weaning of morphine, doctors will consider what the nurses and the parents observe and daily exams into decision making

Buprenorphine for NAS treatment 63 infants enrolled in study 33 received Morphine for NAS treatment 30 received Buprenorphine Mothers were on methadone at a mean dose of 135

Buprenorphine Morphine Median duration of treatment 15 days Median Length of stay 21 days Adjunctive phenobarbital administered in 5/33 infants Median duration of treatment 28 days Median length of stay 33 days Adjunctive phenobarbital 7/30 infants

Probably no correlation unless comparing very low dose, less than 20 to 40 mg/d, to high dose, greater than 90mg/d. In a study by Jansoon et al in Pediatrics 2008 looking at methadone in breast milk during the first 30 days of life found no correlation between maternal methadone dose and maternal plasma level, the amount of methadone in breast milk, incidence of NAS, and infant plasma level for methadone The infant who clears the drug fastest appears to be at higher risk for NAS compared to infants who clear the drug more slowly

ACES

RESULTS: Sixty-six percent (n = 6015) of women reported > or = 1 ACE. Teen pregnancy occurred in 0 16%, 1 21%, 2 26%, 3 29%, 4 32%, 5 40%, 6 43%, 7-8 53% As the ACE score rises odds ratio rises for; family problems, financial problems, job problems, high stress and uncontrolled anger The ACE score was associated with increased fetal death after first pregnancy. With each ACE score the CONCLUSIONS: The relationship between ACEs and adolescent pregnancy is strong and graded. Moreover, the negative psychosocial sequelae and fetal deaths commonly attributed to adolescent pregnancy seem to result from underlying ACEs rather than adolescent pregnancy per se.

Mean length of hospital stay: 23 days Mean hospital charge: $93,400 per infant Total cost: $1.5 billion Medicaid is most common payer ($1.2 billion)

Morphine Treatment for NAS Neonatal Morphine Solution Concentration: 0.4mg/ml Dosage range: 0.03-0.2mg/kg/dose every 3-24 hours Morphine is a pure mu receptor opioid agonist. Half-life range is 4-13 hours CNS and respiratory depression Sedation Constipation

Clonidine Clonidine Concentration: 20mcg/ml Dosage range: 1-3 mcg/kg/dose every 6 hours Clonidine is used as an adjunctive therapy with opiates. Clonidine is a central alpha 2 adrenergic receptor agonist. It reduces sympathetic outflow by decreasing central catecholamine release which is thought to palliate symptoms of autonomic over activity

Clonidine Side Effects Bradycardia Hypotension Withdrawal Hypertension

Clonidine decreases the autonomic symptoms of NAS 1984 a pilot study, 7 infants, using Clonidine as a single agent for NAS Agthe et al 2009 performed a randomized placebo controlled blinded study comparing Dilute Tincture of Opium and placebo and DTO and Clonidine 80 infants, 40 in each group Primary outcome was the duration of opioid therapy

The incidence of maternal opioid addiction is rising We cannot predict which newborns will require pharmacological treatment for opioid addiction based on the mother s methadone dose BF or BM may decrease or obviate the need for NAS treatment AAP recommends treating opioid withdrawal with morphine or methadone There is more expert opinion than evidence based medicine in the treatment of NAS

Check your own bias Mother s struggling with addiction and dependence already struggle with the disease of addiction. Lack family support, lack social support, housing problems, food insecurity, also financial struggles, and legal consequences. Any mother needs all the help they can get!

No mother needs additional guilt for their medical/genetic/ complications

References NEJM med 2017; 376:2341-8. DOI: 10.1056/NEJ MOA 1614835 https://www.cdc.gov/cdcgrandrounds/archives/2017/january2017.htm https://www.cdc.gov/cdcgrandrounds/pdf/archives/2016/august2016.pdf Pediatric Neurology 53 (2015) 445-447 Neonatal Gabapentin withdrawal Syndrome Melisa Carrasco MD, PhD, Sanajai C Rao DO, Cynthia F Bearer MD, PhD, Sripriya Sundararajan MBBS, MD Dr. Connie Adkisson MD HCMC Medical Director NBICU The association between adverse childhood experiences and adolescent pregnancy, long-term psychosocial consequences, and fetal death. Hillis SD 1, Anda RF, Dube SR, Felitti VJ, Marchbanks PA, Marks JS.

Thank You!